ArticleFrontiers in oncology2026

Poly(ADP-ribose) polymerase inhibitor maintenance therapy in ovarian cancer: a single-center retrospective study.

Sydney Pence et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.